Compare Ravinder Heights with Similar Stocks
Dashboard
Poor Management Efficiency with a low ROE of 3.18%
- The company has been able to generate a Return on Equity (avg) of 3.18% signifying low profitability per unit of shareholders funds
Flat results in Jun 26
With ROE of 13.5, it has a Expensive valuation with a 0.7 Price to Book Value
Below par performance in long term as well as near term
Total Returns (Price + Dividend) 
Ravinder Heights for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Ravinder Heights Ltd is Rated Sell
Ravinder Heights Ltd is rated Sell by MarketsMOJO, with this rating last updated on 04 February 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 27 August 2026, providing investors with an up-to-date view of its fundamentals, returns, and market standing.
Read full news article
Ravinder Heights Ltd is Rated Sell by MarketsMOJO
Ravinder Heights Ltd is rated Sell by MarketsMOJO, with this rating last updated on 04 February 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 16 August 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and technical outlook.
Read full news article Announcements 
Announcement under Regulation 30 (LODR)-Newspaper Publication
08-Aug-2026 | Source : BSECopies of newspaper publication for declaration of unaudited(Standalone & Consolidated) Financial results for the quarter ended June 30 2026
Intimation Of Re-Appointment Of Internal Auditor For The Financial Year 2026-27
07-Aug-2026 | Source : BSEIntimation of Re-appointment of internal auditor for the Financial Year 2026-27
Board Meeting Outcome for Outcome Of Board Meeting For Declaration Of Unaudited Standalone And Consolidated Financial Results For The Quarter Ended June 30 2026
07-Aug-2026 | Source : BSEOutcome of board meeting for declaration of unaudited standalone and consolidated financial results for the quarter ended June 30 2026
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Jun 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 0 FIIs
Sunanda Jain (74.74%)
Serum Institute Of India Pvt Ltd (4.34%)
17.59%
Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ
QoQ Growth in quarter ended Jun 2026 is 0.00% vs -99.95% in Mar 2026
QoQ Growth in quarter ended Jun 2026 is 42.52% vs -123.56% in Mar 2026
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 18,280.00% vs -6.25% in Sep 2024
Growth in half year ended Sep 2025 is 8,472.34% vs -135.00% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is 16,979.55% vs -6.38% in Dec 2024
YoY Growth in nine months ended Dec 2025 is 3,299.38% vs 11.96% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is 13,085.96% vs -8.06% in Mar 2025
YoY Growth in year ended Mar 2026 is 2,024.80% vs -18.14% in Mar 2025






